Cargando…

Comparative study of reliability of inflammatory markers over 18-FDG−PET CT scan in monitoring skull base osteomyelitis

INTRODUCTION: The end point of treatment in skull base osteomyelitis is a matter of debate. A treatment based on symptoms alone is fraught with recurrence. There is a need to restrict imaging though more informative. The inflammatory markers like C-reactive protein and erythrocyte sedimentation rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Faizal, Bini, Surendran, Bhavya, Kumar, Madhumita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483943/
https://www.ncbi.nlm.nih.gov/pubmed/33229289
http://dx.doi.org/10.1016/j.bjorl.2020.09.012
_version_ 1784791779452649472
author Faizal, Bini
Surendran, Bhavya
Kumar, Madhumita
author_facet Faizal, Bini
Surendran, Bhavya
Kumar, Madhumita
author_sort Faizal, Bini
collection PubMed
description INTRODUCTION: The end point of treatment in skull base osteomyelitis is a matter of debate. A treatment based on symptoms alone is fraught with recurrence. There is a need to restrict imaging though more informative. The inflammatory markers like C-reactive protein and erythrocyte sedimentation rate used commonly need a detailed evaluation to optimize its utility. OBJECTIVES: To compare the diagnostic accuracy of inflammatory markers with a hybrid PET scan in monitoring skull base osteomyelitis. The secondary objective was to obtain a cut-off value of these markers to decide upon antibiotic termination. METHODS: A prospective cohort study was conducted in a tertiary care center with fifty-one patients with skull base osteomyelitis meeting eligibility criteria. Patients diagnosed with skull base osteomyelitis were serially monitored with weekly markers and PET scan after the initiation of treatment. A hybrid scan was taken at 6–8 weeks of treatment and repeated if required. The follow-up period varied from 6 weeks to 15 months. The outcome measures studied were the values of markers and the metabolic activity of PET scan when the patient became asymptomatic and when disease-free. RESULTS: C-reactive protein and erythrocyte sedimentation rate had a statistically significant correlation to disease activity in PET tomography scan as a prognostic marker. Both showed good clinical correlation. A cut off value of ≤ 3.6 mg/L for C-reactive protein and ≤ 35 mm/hour for erythrocyte sedimentation rate were taken as normalized values. CONCLUSION: A consistent normalized value of C-reactive protein and erythrocyte sedimentation rate for 8–12 weeks in an asymptomatic patient may be an indicator of disease control, though not cure. So, relying solely on markers alone for antibiotic termination may cause relapse. It may be used cautiously in a peripheral setting without access to more specific hybrid scans. In a tertiary care, follow-up scans may be done based on the titres, thereby limiting the radiation exposure.
format Online
Article
Text
id pubmed-9483943
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94839432022-09-20 Comparative study of reliability of inflammatory markers over 18-FDG−PET CT scan in monitoring skull base osteomyelitis Faizal, Bini Surendran, Bhavya Kumar, Madhumita Braz J Otorhinolaryngol Original Article INTRODUCTION: The end point of treatment in skull base osteomyelitis is a matter of debate. A treatment based on symptoms alone is fraught with recurrence. There is a need to restrict imaging though more informative. The inflammatory markers like C-reactive protein and erythrocyte sedimentation rate used commonly need a detailed evaluation to optimize its utility. OBJECTIVES: To compare the diagnostic accuracy of inflammatory markers with a hybrid PET scan in monitoring skull base osteomyelitis. The secondary objective was to obtain a cut-off value of these markers to decide upon antibiotic termination. METHODS: A prospective cohort study was conducted in a tertiary care center with fifty-one patients with skull base osteomyelitis meeting eligibility criteria. Patients diagnosed with skull base osteomyelitis were serially monitored with weekly markers and PET scan after the initiation of treatment. A hybrid scan was taken at 6–8 weeks of treatment and repeated if required. The follow-up period varied from 6 weeks to 15 months. The outcome measures studied were the values of markers and the metabolic activity of PET scan when the patient became asymptomatic and when disease-free. RESULTS: C-reactive protein and erythrocyte sedimentation rate had a statistically significant correlation to disease activity in PET tomography scan as a prognostic marker. Both showed good clinical correlation. A cut off value of ≤ 3.6 mg/L for C-reactive protein and ≤ 35 mm/hour for erythrocyte sedimentation rate were taken as normalized values. CONCLUSION: A consistent normalized value of C-reactive protein and erythrocyte sedimentation rate for 8–12 weeks in an asymptomatic patient may be an indicator of disease control, though not cure. So, relying solely on markers alone for antibiotic termination may cause relapse. It may be used cautiously in a peripheral setting without access to more specific hybrid scans. In a tertiary care, follow-up scans may be done based on the titres, thereby limiting the radiation exposure. Elsevier 2020-10-31 /pmc/articles/PMC9483943/ /pubmed/33229289 http://dx.doi.org/10.1016/j.bjorl.2020.09.012 Text en © 2020 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier Editora Ltda. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Faizal, Bini
Surendran, Bhavya
Kumar, Madhumita
Comparative study of reliability of inflammatory markers over 18-FDG−PET CT scan in monitoring skull base osteomyelitis
title Comparative study of reliability of inflammatory markers over 18-FDG−PET CT scan in monitoring skull base osteomyelitis
title_full Comparative study of reliability of inflammatory markers over 18-FDG−PET CT scan in monitoring skull base osteomyelitis
title_fullStr Comparative study of reliability of inflammatory markers over 18-FDG−PET CT scan in monitoring skull base osteomyelitis
title_full_unstemmed Comparative study of reliability of inflammatory markers over 18-FDG−PET CT scan in monitoring skull base osteomyelitis
title_short Comparative study of reliability of inflammatory markers over 18-FDG−PET CT scan in monitoring skull base osteomyelitis
title_sort comparative study of reliability of inflammatory markers over 18-fdg−pet ct scan in monitoring skull base osteomyelitis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483943/
https://www.ncbi.nlm.nih.gov/pubmed/33229289
http://dx.doi.org/10.1016/j.bjorl.2020.09.012
work_keys_str_mv AT faizalbini comparativestudyofreliabilityofinflammatorymarkersover18fdgpetctscaninmonitoringskullbaseosteomyelitis
AT surendranbhavya comparativestudyofreliabilityofinflammatorymarkersover18fdgpetctscaninmonitoringskullbaseosteomyelitis
AT kumarmadhumita comparativestudyofreliabilityofinflammatorymarkersover18fdgpetctscaninmonitoringskullbaseosteomyelitis